Ergotamine use in severe diabetic autonomic neuropathy.
Richardson
T
T
Kerr
D
D
D002110:Caffeine / Q000627:therapeutic use*; D003929:Diabetic Neuropathies / Q000188:drug therapy*; D019587:Dietary Supplements; D004878:Ergotamine / Q000627:therapeutic use*; D006801:Humans; D014662:Vasoconstrictor Agents / Q000627:therapeutic use
D014662:Vasoconstrictor Agents; D002110:Caffeine; D004878:Ergotamine